- Home
- KRYS vs UBSI Comparison
KRYS vs UBSI Comparison
Compare KRYS & UBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- UBSI
- Stock Information
- Founded
- KRYS 2015
- UBSI 1982
- Country
- KRYS United States
- UBSI United States
- Employees
- KRYS N/A
- UBSI N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- UBSI Major Banks
- Sector
- KRYS Health Care
- UBSI Finance
- Exchange
- KRYS Nasdaq
- UBSI Nasdaq
- Market Cap
- KRYS 4.7B
- UBSI 5.1B
- IPO Year
- KRYS 2017
- UBSI N/A
- Fundamental
- Price
- KRYS $196.65
- UBSI $36.55
- Analyst Decision
- KRYS Strong Buy
- UBSI Hold
- Analyst Count
- KRYS 9
- UBSI 3
- Target Price
- KRYS $214.22
- UBSI $41.83
- AVG Volume (30 Days)
- KRYS 316.5K
- UBSI 781.2K
- Earning Date
- KRYS 11-03-2025
- UBSI 10-23-2025
- Dividend Yield
- KRYS N/A
- UBSI 4.09%
- EPS Growth
- KRYS 275.72
- UBSI 15.26
- EPS
- KRYS 6.66
- UBSI 3.05
- Revenue
- KRYS $373,164,000.00
- UBSI $1,127,073,000.00
- Revenue This Year
- KRYS $34.33
- UBSI $23.91
- Revenue Next Year
- KRYS $48.04
- UBSI $4.64
- P/E Ratio
- KRYS $29.71
- UBSI $11.85
- Revenue Growth
- KRYS 54.51
- UBSI 11.50
- 52 Week Low
- KRYS $122.80
- UBSI $30.51
- 52 Week High
- KRYS $212.98
- UBSI $44.43
- Technical
- Relative Strength Index (RSI)
- KRYS 59.19
- UBSI 50.20
- Support Level
- KRYS $194.92
- UBSI $35.31
- Resistance Level
- KRYS $212.98
- UBSI $36.69
- Average True Range (ATR)
- KRYS 8.35
- UBSI 0.70
- MACD
- KRYS -0.17
- UBSI 0.10
- Stochastic Oscillator
- KRYS 42.14
- UBSI 59.59
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About UBSI United Bankshares Inc.
United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which accepts deposits, makes loans (for personal, credit card, commercial, and construction uses), provides brokerage services, safe deposit boxes, and related services.